Powder: -20°C for 3 years | In solvent: -80°C for 1 year
JNJ-37822681 has potential for the treatment of schizophrenia and bipolar disorder.JNJ-37822681 dihydrochloride is a potent, specific, centrally active, fast-dissociating dopamine D2 receptor antagonist with a moderate binding affinity for the dopamine D2
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 13,000 | |||
5 mg | 在庫あり | ¥ 27,000 | |||
10 mg | 在庫あり | ¥ 37,500 | |||
25 mg | 在庫あり | ¥ 62,000 | |||
50 mg | 在庫あり | ¥ 91,500 | |||
100 mg | 在庫あり | ¥ 136,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 32,500 |
ターゲット&IC50 | D2:0.39 mg/kg(ED50), D2:158 nM(Ki) |
分子量 | 445.26 |
分子式 | C17H19Cl2F5N4 |
CAS No. | 2108806-02-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33.33 mg/mL (74.86 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
JNJ-37822681 dihydrochloride 2108806-02-4 GPCR/G Protein Neuroscience Dopamine Receptor d-amphetamine phencyclidine JNJ-37822681 Dihydrochloride JNJ37822681 Dihydrochloride JNJ 37822681 Dihydrochloride bipolar disorder schizophrenia JNJ37822681 dihydrochloride apomorphine JNJ-37822681 JNJ 37822681 dihydrochloride JNJ37822681 Inhibitor JNJ 37822681 inhibit inhibitor